M Shtalrid
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 14
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 2
- Genetics 9
- Chronic Lymphocytic Leukemia Research 7
- Co-authors
- Moshe TalpazMark BlickRazelle KurzrockA BerrébiJordan U. GuttermanJosé M. TrujilloG YoffeH Kantarjian
- Journals
- Blood (4 papers)Acta Haematologica (1 paper)Journal of Clinical Oncology (1 paper)Journal of Inherited Metabolic Disease (1 paper)American Journal of Hematology (1 paper)
- Partner nations
- IsraelUnited States
In The Last Decade
M Shtalrid
28 papers receiving 445 citations
Peers
Comparison fields: 5 of 51
- Hematology 309
- Genetics 213
- Rheumatology 81
- Pathology and Forensic Medicine 66
- Public Health, Environmental and Occupational Health 78
Countries citing papers authored by M Shtalrid
This map shows the geographic impact of M Shtalrid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Shtalrid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Shtalrid more than expected).
Fields of papers citing papers by M Shtalrid
This network shows the impact of papers produced by M Shtalrid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Shtalrid. The network helps show where M Shtalrid may publish in the future.
Co-authors
The 25 scholars most cited alongside M Shtalrid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 5 | |
| 2 | 2007 | 10 | |
| 3 | 2004 | 2 | |
| 4 | 2002 | 15 | |
| 5 | 2001 | 3 | |
| 6 | 2000 | 12 | |
| 7 | 1998 | 4 | |
| 8 | Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience. | 1995 | 2 |
| 9 | 1995 | 2 | |
| 10 | 1994 | 14 | |
| 11 | 1993 | 5 | |
| 12 | Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemia. | 1989 | 11 |
| 13 | Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor gene. | 1988 | 15 |
| 14 | 1988 | 38 | |
| 15 | 1988 | 67 | |
| 16 | 1988 | 5 | |
| 17 | 1987 | 77 | |
| 18 | In vitro functions of stromal cells from human and mouse bone marrow. | 1985 | 22 |
| 19 | 1984 | 2 | |
| 20 | Rosetting index (E rosettes/mouse rosettes): a simple diagnostic and prognostic value in CLL. | 1984 | 3 |
About M Shtalrid
M Shtalrid is a scholar working on Hematology, Genetics, Nephrology, Internal Medicine and Oncology, having authored 28 papers that have together received 461 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Erythrocyte Function and Pathophysiology (3 papers), DNA and Nucleic Acid Chemistry (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Hematology (309 citations), Genetics (213 citations), Rheumatology (81 citations), Pathology and Forensic Medicine (66 citations) and Public Health, Environmental and Occupational Health (78 citations). M Shtalrid has collaborated with scholars based in Israel and United States. Frequent co-authors include Moshe Talpaz, Mark Blick, Razelle Kurzrock, A Berrébi, Jordan U. Gutterman, José M. Trujillo, G Yoffe, H Kantarjian, Gutterman Ju and Razelle Kurzrock. Their work appears in journals such as Blood, Acta Haematologica, Journal of Clinical Oncology, Journal of Inherited Metabolic Disease and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.